Related Experiment Videos
Transmembrane proteases as disease markers and targets for therapy
C Antczak1, I De Meester, B Bauvois
1Unité 365 Inserm, Institut Curie, Paris, France.
Journal of Biological Regulators and Homeostatic Agents
|August 15, 2001
Summary
Transmembrane proteases, also known as ectoproteases, are enzymes found in many cell types. Inhibitors reveal their role in modulating cell functions and their potential as disease markers and therapeutic targets.
Area of Science:
- Biochemistry
- Cell Biology
- Enzymology
Background:
- Transmembrane proteases (ectoproteases) are enzymes located on cell surfaces.
- They are expressed in diverse cell types, including endothelial, epithelial, and hematopoietic cells.
- These proteases play roles in modulating cellular functions.
Purpose of the Study:
- To investigate the biological roles of transmembrane proteases.
- To explore their involvement in major cellular events like proliferation, survival, and invasiveness.
- To assess their potential as disease biomarkers and therapeutic targets.
Main Methods:
- Characterization of natural and synthetic inhibitors of transmembrane proteases.
- Analysis of ectoenzyme activity and its impact on bioactive peptide responses.
- Investigation of dysregulated expression patterns in human diseases.
Main Results:
- Ectoenzymes modulate bioactive peptide responses.
- Transmembrane proteases influence critical cellular processes such as proliferation, survival, and invasiveness.
- Dysregulated expression is linked to human diseases.
Conclusions:
- Transmembrane proteases are key regulators of cellular functions.
- Their dysregulation in disease highlights their pathophysiological significance.
- These enzymes represent promising targets for therapeutic intervention and diagnostic markers.